Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marloes A. Smit"'
Autor:
Marloes A. Smit, Francesco Ciompi, John-Melle Bokhorst, Gabi W. van Pelt, Oscar G.F. Geessink, Hein Putter, Rob A.E.M. Tollenaar, J. Han J.M. van Krieken, Wilma E. Mesker, Jeroen A.W.M. van der Laak
Publikováno v:
Journal of Pathology Informatics, Vol 14, Iss , Pp 100191- (2023)
Background: The amount of stroma within the primary tumor is a prognostic parameter for colon cancer patients. This phenomenon can be assessed using the tumor–stroma ratio (TSR), which classifies tumors in stroma-low (≤50% stroma) and stroma-high
Externí odkaz:
https://doaj.org/article/952a24ce6a9e4d6997d223435ccde130
Autor:
Simone van de Weerd, Marloes A. Smit, Jessica Roelands, Wilma E. Mesker, Davide Bedognetti, Peter J. K. Kuppen, Hein Putter, Rob A. E. M. Tollenaar, Jeanine M. L. Roodhart, Wouter Hendrickx, Jan Paul Medema, J. Han J. M. van Krieken
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12707 (2022)
The purpose of this study was to evaluate the association between four distinct histopathological features: (1) tumor infiltrating lymphocytes, (2) mucinous differentiation, (3) tumor-stroma ratio, plus (4) tumor budding and two gene expression-based
Externí odkaz:
https://doaj.org/article/03127fd343a043a284340e55418fca01
Autor:
Marloes A Smit, Wilma E Mesker
Publikováno v:
EBioMedicine, Vol 61, Iss , Pp 103070- (2020)
Externí odkaz:
https://doaj.org/article/63a76c34866a47d8a9eb3727da5a436e
Autor:
Meaghan Polack, Marloes A. Smit, Stijn A.L.P. Crobach, Valeska Terpstra, Annet G.H. Roodvoets, Elma M. Meershoek-Klein Kranenbarg, Els M.C. Dequeker, Jeroen A. van der Laak, Rob A.E.M. Tollenaar, Han J.H.J.M. van Krieken, Wilma E. Mesker
Publikováno v:
European Journal of Surgical Oncology. 49:e132-e133
Autor:
Gabi W. van Pelt, J. Han van Krieken, Rob A. E. M. Tollenaar, Valeska Terpstra, Wilma E. Mesker, Marloes A Smit, Hein Putter
Publikováno v:
International Journal of Colorectal Disease, 36, 2729-2737. SPRINGER
International Journal of Colorectal Disease
International Journal of Colorectal Disease
The tumour-stroma ratio (TSR) and tumour budding (TB) are two high-risk factors with potential to be implemented in the next TNM classification. The aim of the current study was to evaluate the practical application of the two biomarkers based on rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60271eed0fdd826fd8fd7f72004618cb
http://hdl.handle.net/1887/3277473
http://hdl.handle.net/1887/3277473
Autor:
Pieter E. Postmus, Marloes A Smit, Wilma E. Mesker, Danielle Cohen, Mark Wh Philipsen, Rob A. E. M. Tollenaar, Hein Putter
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100247-(2020)
Objectives The tumor-stroma ratio (TSR) is based on the relative amount of stroma in the primary tumor and has proven to be an independent prognostic factor in various solid tumors. The prognosis of patients and adjuvant treatment decision making in
Autor:
Julia E.C. van Steenhoven, Marloes A Smit, Wilma E. Mesker, Thijs van Dalen, Rob A. E. M. Tollenaar, Paul J. van Diest
Publikováno v:
Journal of Surgery and Research, 3(2), 112-118. Fortune Journals
Background: Strategies for breast cancer care are improving. However, there is a clinical need for a better selection of patients who are at risk for recurrence and benefit from treatment with chemotherapy. The 70-gene signature (70-GS) guides chemot
SO-16 The tumour-stroma ratio as an additional parameter to the TNM classification: The UNITED study
Autor:
Hans Gelderblom, Wilma E. Mesker, H. van Krieken, G W van Pelt, Marloes A Smit, R.A.E.M. Tollenaar
Publikováno v:
Annals of Oncology. 31:S222-S223
Autor:
Gabi W. van Pelt, J. Han van Krieken, Wilma E. Mesker, Annet G H Roodvoets, Marloes A Smit, Hein Putter, Elma Meershoek-Klein Kranenbarg, Rob A. E. M. Tollenaar
Publikováno v:
JMIR Research Protocols
JMIR Research Protocols, 8(6)
JMIR Research Protocols, 8(6)
Background: Colon cancer treatment is dependent on the stage at diagnosis. The current Tumor-Node-Metastasis (TNM) staging for the selection of patients for adjuvant chemotherapy needs additional prognostic and predictive biomarkers. Better decision
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8c24823a0f70f3e1878bdd185d9eb7
https://hdl.handle.net/1887/86912
https://hdl.handle.net/1887/86912
Autor:
Elisabeth Dequeker, Raed Al Dieri, Gabi W. van Pelt, J. Han van Krieken, Rob A. E. M. Tollenaar, Wilma E. Mesker, Marloes A Smit
Publikováno v:
JMIR Formative Research
JMIR Formative Research, Vol 5, Iss 3, p e19408 (2021)
JMIR Formative Research, Vol 5, Iss 3, p e19408 (2021)
Background The amount of stroma in the primary tumor is an important prognostic parameter. The tumor-stroma ratio (TSR) was previously validated by international research groups as a robust parameter with good interobserver agreement. Objective The U